Intellectual Property and Business Development Committee

The MaineHealth Intellectual Property and Business Development Committee is appointed by the Chief Academic Officer with approval from the MaineHealth Chief Executive Officer, MaineHealth President and Maine Medical Center President.

The Committee is responsible for the following:

  • Making recommendations on whether and/or how much of MaineHealth resources to invest to support the development of an invention
  • When to license, to whom, and for how much: or to sell outright, if possible.
  • Whether to take ownership position in a company that will develop/market as part of license fee

Intellectual Property and Business Development Committee

Susan Ahern
VP of Innovation, MaineHealth
Chair

Brady Bohrmann
Managing Director, Avalon Ventures
Committee Member

Britt Crewse
Southern Region President, MaineHealth
Executive Sponsor

Robert Frank
Counsel – Special Projects, MaineHealth
Committee Member

Tom Gridley, PhD
Faculty Scientist III, MaineHealth Institute for Research
Committee Member

Beth Kelsch
General Counsel, MaineHealth
Committee Member

Robert King
Former Investor, Goldman Sachs
Committee Member

Adrian Moran
Chief Medical and Transformation Officer, MaineHealth
Committee Member

Andy Mueller, MD
CEO, MaineHealth
Executive Sponsor

Dan Nigrin, MD
Chief Information Officer, MaineHealth
Committee Member

Rich Parker, MS, CBET
Vice President Sales USA, PT MedTech
Committee Member

Doug Sawyer, MD, PhD
Chief Academic Officer & Interim Chief Medical Officer, MaineHealth
Executive Sponsor

Al Swallow III
Chief Financial Officer, MaineHealth
Committee Member

Stuart Watson
Entrepreneur & Board of Trustees member, MaineHealth Maine Medical Center & MaineHealth
Committee Member

David Yarin
Alliance Manager, Music Partnerships
Committee Member